ARTICLE | Clinical News

PD-02: Phase II data

March 20, 2006 8:00 AM UTC

Data from a double-blind, U.S. and Canadian Phase II trial in 200 early, untreated PD patients showed that 12 months of daily treatment with 10 mg PD-02 or 200 mg minocycline antibiotic led to a lower...